首页> 美国卫生研究院文献>Biotechnology for Biofuels >Production of C2–C4 diols from renewable bioresources: new metabolic pathways and metabolic engineering strategies
【2h】

Production of C2–C4 diols from renewable bioresources: new metabolic pathways and metabolic engineering strategies

机译:从可再生生物资源生产C2-C4二醇:新的代谢途径和代谢工程策略

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

C2–C4 diols classically derived from fossil resource are very important bulk chemicals which have been used in a wide range of areas, including solvents, fuels, polymers, cosmetics, and pharmaceuticals. Production of C2–C4 diols from renewable resources has received significant interest in consideration of the reducing fossil resource and the increasing environmental issues. While bioproduction of certain diols like 1,3-propanediol has been commercialized in recent years, biosynthesis of many other important C2–C4 diol isomers is highly challenging due to the lack of natural synthesis pathways. Recent advances in synthetic biology have enabled the de novo design of completely new pathways to non-natural molecules from renewable feedstocks. In this study, we review recent advances in bioproduction of C2–C4 diols, focusing on new metabolic pathways and metabolic engineering strategies being developed. We also discuss the challenges and future trends toward the development of economically competitive processes for bio-based diol production.
机译:经典地源自化石资源的C2-C4二醇是非常重要的散装化学品,已在许多领域使用,包括溶剂,燃料,聚合物,化妆品和药品。考虑到化石资源的减少和环境问题的增加,从可再生资源生产C2-C4二醇引起了极大的兴趣。近年来,虽然某些二醇(如1,3-丙二醇)的生物生产已商业化,但由于缺乏天然合成途径,许多其他重要的C2-C4二醇异构体的生物合成也面临着巨大挑战。合成生物学的最新进展使从头设计从可再生原料到非天然分子的全新途径成为可能。在这项研究中,我们回顾了C2-C4二醇生物生产的最新进展,重点是新的代谢途径和正在开发的代谢工程策略。我们还讨论了发展生物基二醇生产经济竞争性工艺所面临的挑战和未来趋势。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号